Science Explorer Back to mapMap
Discussion
Company · New Haven · United States

Arvinas (United States)

arvinas.comROR OpenAlex
Research works
82
▲ 121% vs 2018-21
Citations
6.5k
79.0 per fractional work
Top-10% rate
26.2%
all institutions 10.0%
Open access
42%
world 40%
International
20%
world 18%
Arvinas (United States)

Not ranked overall: Arvinas (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Arvinas (United States) work in?

In 2022-now, 46% of research at Arvinas (United States) is in Health Sciences, 46% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (44%), Chemistry (2%). It does 2.6× the world's share of Life Sciences.

Health Sciences: 20 fractional works · 46.1% of its workMedicine: 20 fractional works · 46.1% of its workOncology: 12 fractional works · 26.8% of its workPulmonary and Respiratory Medicine: 4 fractional works · 8.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.1% of its workNeurology: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 20 fractional works · 46.1% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 44.1% of its workMolecular Biology: 17 fractional works · 39.5% of its workGenetics: 1 fractional works · 2.0% of its workCancer Research: 1 fractional works · 1.2% of its workCell Biology: 0 fractional works · 1.1% of its workEndocrinology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 4.2% of its workChemistry: 1 fractional works · 2.0% of its workOrganic Chemistry: 1 fractional works · 1.6% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.6% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.6% of its workOcean Engineering: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 3.5% of its workPsychology: 1 fractional works · 1.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.1% of its workSocial Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 1.0% of its workEducation: 0 fractional works · 0.4% of its workSafety Research: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workALL ITS WORKArvinas (UnitedStates)44fractional works, 2022-now
Life Sciences46%Physical Sciences4%Health Sciences46%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine2046.1%
    2. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology1944.1%
    2. Immunology and Microbiology00.8%
    3. Pharmacology, Toxicology and Pharmaceutics00.8%
    4. Agricultural and Biological Sciences00.4%
    5. Neuroscience00.1%
    1. Chemistry12.0%
    2. Computer Science00.7%
    3. Energy00.6%
    4. Engineering00.6%
    5. Mathematics00.4%
    1. Psychology11.5%
    2. Social Sciences01.0%
    3. Economics, Econometrics and Finance00.7%
    4. Decision Sciences00.2%
    5. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Arvinas (United States) specialise in?

Where its research is concentrated relative to its size: Life Sciences takes 3.5× the share of its output that it takes of world research.

  1. Life SciencesDomain · 20.2 works3.5×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.27× its world share, 19 worksBiochemistry, Geneti…Immunology and Microbiology: 0.74× its world share, 0 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.16× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.28× its world share, 1 worksChemistryComputer Science: 0.09× its world share, 0 worksComputer ScienceEnergy: 0.62× its world share, 0 worksEnergyEngineering: 0.04× its world share, 0 worksEngineeringMathematics: 0.32× its world share, 0 worksMathematicsHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 2.40× its world share, 20 worksMedicineBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.20× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.33× its world share, 0 worksEconomics, Econometr…Psychology: 0.50× its world share, 1 worksPsychologySocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.27×19 works
  2. Medicine2.40×20 works
  3. Pharmacology, Toxicology and Pharmaceutics2.16×0 works
  4. Chemistry1.28×1 works
  5. Immunology and Microbiology0.74×0 works
  6. Energy0.62×0 works
  7. Psychology0.50×1 works
  8. Economics, Econometrics and Finance0.33×0 works
  9. Mathematics0.32×0 works
  10. Decision Sciences0.20×0 works
  11. Agricultural and Biological Sciences0.09×0 works
  12. Computer Science0.09×0 works
  13. Social Sciences0.08×0 works
  14. Neuroscience0.07×0 works
  15. Engineering0.04×0 works
  16. Health Professions0.03×0 works
  17. Business, Management and Accounting0.02×0 works

Who are the top researchers at Arvinas (United States)?

Ranked on the quality score, Hanqing Dong, Andrew P. A. Crew and Tom Januario lead among researchers whose main affiliation is Arvinas (United States).

  1. 1 Hanqing Dong United States · #382,923 worldwide 6.3k citations · 81 works
  2. 2 Andrew P. A. Crew United States · #536,709 worldwide 5.1k citations · 82 works
  3. 3 Tom Januario United States · #562,641 worldwide 1.1k citations · 43 works
  4. 4 Kevin G. Coleman United States · #625,659 worldwide 6.8k citations · 121 works
  5. 5 Jennifer Pizzano United States · #723,104 worldwide 1.2k citations · 57 works
  6. 6 Richard W. Gedrich United States · #729,697 worldwide 3.5k citations · 113 works
  7. 7 Ryan R. Willard United States · #795,902 worldwide 2.7k citations · 41 works
  8. 8 Elizabeth Bortolon United States · #879,238 worldwide 940 citations · 28 works
  9. 9 Deborah A. Gordon United States · #1,350,362 worldwide 2.4k citations · 22 works
  10. 10 Emma Rousseau United States · #1,584,866 worldwide 724 citations · 35 works
All ranked researchers at Arvinas (United States)

What are the most cited papers from Arvinas (United States)?

The most cited paper from Arvinas (United States) is "PROTAC targeted protein degraders: the past is prologue" (Miklós Békés, David R. Langley, Craig M. Crews, 2022), with 3,294 citations. Next come "Catalytic in vivo protein knockdown by small-molecule PROTACs" (1,365) and "Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4" (1,162).

Most cited papers
#PaperReleasedCitations
1 PROTAC targeted protein degraders: the past is prologue Miklós Békés, David R. Langley, Craig M. Crews · Nature Reviews Drug Discovery ReviewOpen access 18 Jan 2022 3,294
2 Catalytic in vivo protein knockdown by small-molecule PROTACs Daniel P. Bondeson et al. · Nature Chemical Biology Open access 10 Jun 2015 1,365
3 Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Jing Lü, Yimin Qian, Martha Altieri et al. · Chemistry & Biology Open access Jun 2015 1,162
4 Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead Daniel P. Bondeson, Blake E. Smith, George M. Burslem et al. · Cell chemical biology Open access 9 Nov 2017 938
5 PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Kanak Raina, Jing Lü, Yimin Qian et al. · Proceedings of the National Academy of Sciences Open access 6 Jun 2016 855
All 59 most cited papers, with filters and sorting

Which keywords describe research at Arvinas (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Transcriptional Regulation, BET Bromodomains, PROTACs, Cancer Therapy, Breast Cancer, PET Imaging, Tumor Microenvironment and Fibroblast Activation Protein.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Transcriptional Regulation11▲ 155×2 topics
  2. BET Bromodomains11▲ 779×1 topic
  3. PROTACs11▲ 779×1 topic
  4. Cancer Therapy10▲ 39×6 topics
  5. Breast Cancer7▲ 61×5 topics
  6. PET Imaging6▲ 83×3 topics
  7. Tumor Microenvironment6▲ 30×2 topics
  8. Fibroblast Activation Protein5▲ 280×1 topic
  9. Immunosuppression5▲ 132×1 topic
  10. Immunotherapy4▲ 13×4 topics
  11. Chemotherapy4▲ 12×2 topics
  12. HER23▲ 236×1 topic
  13. Trastuzumab3▲ 151×1 topic
  14. Cell Cycle Control3▲ 192×2 topics
  15. Metastatic Breast Cancer3▲ 101×2 topics
  16. Gene Expression2▲ 9.2×4 topics
  17. CDK4/6 Inhibitors2▲ 196×1 topic
  18. Palbociclib2▲ 196×1 topic
  19. Proteasome Inhibitors2▲ 78×2 topics
  20. Epigenetic Regulation2▲ 24×2 topics
  21. HDAC Inhibitors2▲ 232×1 topic
  22. Histone Deacetylases2▲ 232×1 topic
  23. Lymphoma2▲ 31×2 topics
  24. Genetic Mutations2▲ 10×4 topics
  25. CAR T Cells2▲ 58×1 topic
  26. Chimeric Antigen Receptor2▲ 58×1 topic
  27. Proteasome2▲ 110×1 topic
  28. Staging System2▲ 62×2 topics
  29. Ubiquitin2▲ 110×1 topic
  30. Clinical Trials1▲ 4.7×5 topics
  31. Biomarkers1▲ 4.4×3 topics
  32. Hormone Therapy1▲ 31×2 topics
  33. Prostate Cancer1▲ 18×2 topics

Which research topics does Arvinas (United States) publish most on?

By volume in 2022-now: Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, HER2/EGFR in Cancer Research and Advanced Breast Cancer Therapies.

Protein Degradation and …11Protein Degradation and Inhibitors: 11 fractional worksPeptidase Inhibition and Analysis: 5 fractional worksHER2/EGFR in Cancer Research: 3 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksHistone Deacetylase Inhi…2Histone Deacetylase Inhibitors Research: 2 fractional worksCAR-T cell therapy research: 2 fractional worksUbiquitin and proteasome pathways: 2 fractional worksNeuroblastoma Research and Treatments: 1 fractional worksProstate Cancer Treatment and Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional works
Molecular BiologyOncologyPulmonary and Respiratory MedicineNeurology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 11 works
  2. 2 Peptidase Inhibition and Analysis Oncology 5 works
  3. 3 HER2/EGFR in Cancer Research Oncology 3 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  5. 5 Histone Deacetylase Inhibitors Research Molecular Biology 2 works
  6. 6 CAR-T cell therapy research Oncology 2 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 2 works
  8. 8 Neuroblastoma Research and Treatments Neurology 1 works
  9. 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.6%not open58.4%

World: 40% of research is openly available.

with international co-authors19.6%domestic only80.4%

World: 18% is written across borders.

How has Arvinas (United States)'s research output changed?

Output in 2022-2025 was 121% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Arvinas (United States) as a percentage of every work published that year, 0.00020% in 2024.

still counting0.00010%0.00020%0.00030%Arvinas (United States)0.00022% in 202519801990200020102020

Fractional works of Arvinas (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in New Haven

All research institutions in New Haven

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Arvinas (United States). Posts are plain text and can be reported.